Breaking News, Financial News

New Chief Strategy Officer for Sanofi

Gros to manage BD, acquisition activities as of September

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Dr. David-Alexandre Gros has been named chief strategy officer of Sanofi, effective September 1, 2011. He will report to Christopher A. Viehbacher, Sanofi’s chief executive officer, and will join the Group Executive Committee. He will be based in Paris, France. Dr. Gros’ position will cover all Group business development and acquisition activities as well as strategic planning, economic evaluation of projects, strategic intelligence, and alliance management. Mr. Viehbacher remarked,...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters